Po Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Research progress on tumor extracellular matrix stiffness and immunosuppression.

Research progress on tumor extracellular matrix stiffness and immunosuppression.

Journal: Frontiers in immunology

Published: April 10, 2026

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system.

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: October 07, 2025

Multi-Transcriptomic Analysis Reveals GSC-Driven MES-Like Differentiation via EMT in GBM Cell-Cell Communication.

Multi-Transcriptomic Analysis Reveals GSC-Driven MES-Like Differentiation via EMT in GBM Cell-Cell Communication.

Journal: Biomedicines

Published: March 26, 2025

Global, regional, and national burden of disease attributable to a diet low in milk, 1990-2021: An updated analysis of the Global Burden of Disease study 2021.

Global, regional, and national burden of disease attributable to a diet low in milk, 1990-2021: An updated analysis of the Global Burden of Disease study 2021.

Journal: Journal of dairy science

Published: December 09, 2024

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 11, 2023

FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells.

FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells.

Journal: Neuro-oncology

Published: April 21, 2023

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.

LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization.

Journal: Journal for immunotherapy of cancer

Published: August 10, 2022

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.

Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies.

Journal: Pharmaceutics

Published: June 29, 2022

Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth.

Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth.

Journal: Cell death & disease

Published: May 29, 2022

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment.

Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment.

Journal: Frontiers in oncology

Published: May 08, 2022

TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.

TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.

Journal: Theranostics

Published: November 30, 2021

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas.

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas.

Journal: Frontiers in immunology

Published: November 29, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026